Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations-Reference-Cited by-同舟云学术

Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations

Published:2013-12-11 Issue:11 Volume:21 Page:809-817
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Ayres A.¹,Yuen L.¹,Jackson K. M.¹,Manoharan S.²,Glass A.²,Maley M.²,Yoo W.³,Hong S. P.³,Kim S.-O.³,Luciani F.⁴,Bowden D. S.¹,Bayliss J.¹,Levy M. T.²,Locarnini S. A.¹

Affiliation:

1. Research & Molecular Development; Victorian Infectious Diseases Reference Laboratory; Melbourne Vic. Australia

2. Liverpool Hospital; South West Area Health Service; Sydney NSW Australia

3. Genematrix Inc.; Seoul Seongnam Korea

4. Lowi Cancer Research Centre; University of New South Wales; Sydney NSW Australia

Funder

Genematrix Inc

Ministry of Knowledge and Economy

Bilateral International Collaborative R&D Program

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12212/fullpdf

Reference29 articles.

1. Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B;Chen;J Hepatol,2009

2. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection;Zonneveld;J Viral Hepatitis,2003

3. Hepatitis B in pregnancy;Gambarin-Gelwan;Clin Liver Dis,2007

4. Perinatal transmission of hepatitis B virus: an Australian experience;Wiseman;Med J Aust,2009

5. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study;Xu;J Viral Hepatitis,2009

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unexpected HBsAg decrease after nucleoside analogues re-treatment among HBeAg positive postpartum women: a pilot study.;2024-07-18

2. Safety and Efficacy of Antiviral Drugs and Vaccines in Pregnant Women: Insights from Physiologically Based Pharmacokinetic Modeling and Integration of Viral Infection Dynamics;Vaccines;2024-07-16

3. Vertical Transmission of Hepatitis B Virus—An Update;Microorganisms;2023-04-27

4. Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection;Frontiers in Immunology;2023-01-04

5. Hepatitis B and C in Pregnancy and Children: A Canadian Perspective;Viruses;2022-12-29